
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
GENERALIZED ANALYSIS OF AUTHORIZED MEDICINES FOR THE THERAPY OF COVID-19 IN THE WORLD AND UKRAINE
Popova I.A.*, Nazarkina V.N., Kurylenko Yu. Ye, Vynnyk O.V. and Mischenko V.I.
. Abstract The purpose of the study is a generalized analysis of recommended drugs for the treatment of coronavirus disease. Materials and methods - analysis of scientific publications on the stated topic, generalization of the results. Results. In 2020, the key factor influencing the development of the world's economy was the COVID-19 pandemic and related quarantine restrictions. The pharmaceutical industry, along with health care, has been at the forefront of the world's pandemic fight. Conclusions. In addition to opening up new opportunities for pharmaceuticals in the fight against COVID-19, such as vaccine development and clinical trials of existing drugs for the treatment of COVID-19, the pandemic has deeply affected the supply chain and distribution in the industry and posed significant risks to non-treatment activities. coronavirus. Keywords: COVID-19, therapy, drugs, pharmaceutical market. [Full Text Article] [Download Certificate] |
